Core Insights - Gauzy Ltd. announced the election of Alejandro Weinstein to its Board of Directors, effective November 1, 2025, following the annual general meeting of shareholders [1] - The company aims to adopt a leaner board structure to reduce corporate expenses and maintain agility [1] Company Leadership - Alejandro Weinstein has over 30 years of managerial experience, including serving as CEO of CFR Pharmaceuticals S.A., where he led the company to a multi-billion-dollar sale to Abbott Laboratories [2] - His expertise in global expansion, mergers and acquisitions, and public company leadership is expected to support Gauzy's growth and strategic objectives [2][3] Board Changes - Gal Gitter concluded his service on the Board after his term expired, and Danny Allouche is also stepping down, both recognized for their significant contributions during their tenures [3] - Eyal Peso, CEO and Chairman of Gauzy, expressed gratitude for the contributions of both departing board members, highlighting their roles in the company's growth and strategic direction [3] Company Overview - Gauzy Ltd. specializes in vision and light control technologies, focusing on research, development, manufacturing, and marketing [4] - The company operates globally with subsidiaries in multiple countries, serving various industries including aeronautics, automotive, and architecture [4]